By Michael Susin Dr. Martens said third-quarter revenue fell in line with expectations, dragged by a weak performance in the U.S., and that its guidance for.
By Michael Susin Dr. Martens shares slipped after the group issued another profit warning on the back of a slower-than-anticipated recovery in the U.S..
By Elena Vardon Dr. Martens said that it sees revenue and profit for fiscal 2024 falling as its performance is taking a hit from the challenging consumer.
U.S. futures for the S&P 500 were up 0.2% and futures for the Dow Jones Industrial Average increased 0.4%. Changes in futures do not necessarily predict.
By Michael Susin Dr. Martens shares slip after the group cut its fiscal 2024 targets on the back of a slower-than-anticipated recovery in the U.S. market..